Zytiga generics looming as US court nixes J&J patent

Zytiga generics looming as US court nixes J&J patent

Source: 
Pharmaforum
snippet: 

Johnson & Johnson has lost another round in its patent defense for prostate cancer blockbuster Zytiga, raising the possibility that generics could launch in the coming days.